Volume 10, Number 5—May 2004
Research
Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients
Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*
, and Pan-Chyr Yang*
, and Pan-Chyr Yang*Table 4
Complications found in 76 SARS patientsa
| Complication | No. of patients (%) |
|---|---|
| Rhabdomyolysis |
4 (5.3) |
| Peripheral neuropathy |
5 (6.6) |
| Acute renal failure |
3 (3.9) |
| Gastrointestinal bleeding |
2 (2.6) |
| Acute myocardial infarction |
1 (1.3) |
| Bacteria superinfection |
10 (13.2) |
| Candida parapsilosis superinfection |
1 (1.3) |
| MRSA |
4 (5.3) |
| MRSE |
2 (2.6) |
| Enterococci |
3 (3.9) |
| Acinetobacter baumannii |
3 (3.9) |
| Klebsiella pneumoniae |
2 (2.6) |
| Enterobacter cloacae |
1 (1.3) |
| Serratia marcescense |
1 (1.3) |
| Total | 18 (23.7) |
aSARS, severe acute respiratory syndrome; MRSA, methicillin-resistant Staphylococcus aureus; MRSE, methicillin-resistant Staphylococcus epidermidis. Some patients experience more than one complication.
